Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, ...

The Food and Drug Administration (FDA) has granted Priority Review to enfortumab vedotin-ejfv (Padcev ™) in combination with pembrolizumab (Keytruda ®) as a neoadjuvant treatment and then continued ...

To our knowledge, this is the greatest survival benefit, based upon hazard ratio, ever seen in a prostate cancer,” said study presenter Stephen J. Freedland, MD.

As chair of orthopedics at Cedars-Sinai in Los Angeles, Mark Vrahas, MD, has spent his career building programs that balance excellence in education, clinical care and research.  Today, he sees the ...

• Antibiotics seem to reduce surgical site infections in people undergoing surgery to fix the lower limb arteries (peripheral arterial reconstruction of the lower limb).

Testing showed that Gonzalez’ ALS was caused by a mutation in the SOD1 gene (Super Oxide Dismutase 1), which meant she was ...

The company reported its second late-stage study success, this time with a drug that could become a new treatment standard ...